A newborn boy died within a day of birth after an undetected herpes simplex virus (HSV), passed from his asymptomatic mother, ...

With much of Moderna’s recent rise tied to its COVID-19 vaccine, the company has struggled to match the sales highs it ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 ...

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

The biotechnology firm announced it aims to achieve up to 10% revenue growth in 2026 while working toward cash breakeven by 2028. Moderna plans to expand its seasonal vaccine franchise from three to ...

Moderna’s nearly $20 billion cash hoard has dwindled to a single-digit stash following a series of setbacks for the biotech.

IO360º today announced the 2026 sponsoring companies of the 12th annual Immuno-Oncology 360º Summit (IO360°) to date, who provide the capabilities the IO marketplace needs to advance the science.

Moderna (NASDAQ:MRNA) gained 3% on Thursday after presenting a new multi-year roadmap at its Analyst Day, detailing how it ...

At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set the stage for additional growth ...